Table 1 General characteristics
From: Insulin use in Type 2 diabetic patients: a predictive of mortality in covid‑19 infection
N = 696 | |
|---|---|
Age, median [IQR] | 57 (51–62) |
BMI, median [IQR] | 29.9 (26–34.7) |
Gender | |
Male | 476 (68%) |
Female | 220 (32%) |
Race | |
White | 170 (24%) |
African American | 139 (20%) |
Hispanic | 132 (19%) |
Asian | 65 (9%) |
Multiracial | 190 (27%) |
Smoker | 96 (14%) |
Home Insulin | 227 (33%) |
Metformin | 354 (51%) |
ACE inhibitor/ARB | 310 (45%) |
Hypertension | 481 (69%) |
Intubation | 168 (24%) |
Acute kidney injury | 298 (43%) |
Death | 86 (12%) |